AU2002368062A1 - Bispecific antibodies that bind to vegf receptors - Google Patents
Bispecific antibodies that bind to vegf receptorsInfo
- Publication number
- AU2002368062A1 AU2002368062A1 AU2002368062A AU2002368062A AU2002368062A1 AU 2002368062 A1 AU2002368062 A1 AU 2002368062A1 AU 2002368062 A AU2002368062 A AU 2002368062A AU 2002368062 A AU2002368062 A AU 2002368062A AU 2002368062 A1 AU2002368062 A1 AU 2002368062A1
- Authority
- AU
- Australia
- Prior art keywords
- bind
- bispecific antibodies
- vegf receptors
- vegf
- receptors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091008605 VEGF receptors Proteins 0.000 title 1
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/626—Diabody or triabody
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002345927 | 2002-06-26 | ||
| PCT/US2002/020332 WO2003002144A1 (en) | 2001-06-26 | 2002-06-26 | Bispecific antibodies that bind to vegf receptors |
| PCT/US2002/041372 WO2004003211A1 (en) | 2002-06-26 | 2002-12-24 | Bispecific antibodies that bind to vegf receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002368062A1 true AU2002368062A1 (en) | 2004-01-19 |
Family
ID=29998733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002368062A Abandoned AU2002368062A1 (en) | 2002-06-26 | 2002-12-24 | Bispecific antibodies that bind to vegf receptors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002368062A1 (en) |
| WO (1) | WO2004003211A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1523496T1 (en) | 2002-07-18 | 2011-11-30 | Merus B V | Recombinant production of mixtures of antibodies |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| EP2395017A3 (en) | 2003-05-30 | 2012-12-19 | Merus B.V. | Design and use of paired variable regions of specific binding molecules |
| US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
| PL1660057T3 (en) | 2003-08-27 | 2012-10-31 | Ophthotech Corp | Combination therapy for the treatment of ocular neovascular disorders |
| US7888481B2 (en) | 2005-02-10 | 2011-02-15 | Baylor Research Institute | Anti-interferon alpha monoclonal antibodies and methods for use |
| CA2597265C (en) * | 2005-02-10 | 2015-03-24 | Baylor Research Institute | Anti-interferon alpha monoclonal antibodies and methods for use |
| ES2743399T3 (en) | 2012-04-20 | 2020-02-19 | Merus Nv | Methods and means for the production of Ig-like heterodimeric molecules |
| AU2015282627B2 (en) | 2014-06-30 | 2020-04-02 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
-
2002
- 2002-12-24 AU AU2002368062A patent/AU2002368062A1/en not_active Abandoned
- 2002-12-24 WO PCT/US2002/041372 patent/WO2004003211A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004003211A1 (en) | 2004-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1411983A4 (en) | Bispecific antibodies that bind to vegf receptors | |
| EP1572874A3 (en) | Antibodies that immunospecifically bind to trail receptors | |
| GB0305702D0 (en) | Bispecific antibodies | |
| EP1465925A4 (en) | Antibodies that immunospecifically bind to trail receptors | |
| EP1572874A4 (en) | Antibodies that immunospecifically bind to trail receptors | |
| EP1786918A4 (en) | Novel tetravalent bispecific antibody | |
| IL184152A0 (en) | Monoclonal antibodies against nkg2a | |
| IL182012A0 (en) | Monoclonal antibodies to progastrin | |
| SI2489364T1 (en) | Monomethylvaline compounds conjugated to antibodies | |
| IL212350A0 (en) | Anti-p-selectin antibodies | |
| AU2003218456A1 (en) | Antibodies that specifically bind to gmad | |
| AU2003234706A1 (en) | Antibodies that specifically bind to tl5 | |
| ZA200706185B (en) | Monoclonal antibodies against NKG2A | |
| AU2003256299A1 (en) | Antibodies that specifically bind to reg iv | |
| AU2003240822A1 (en) | Antibodies that specifically bind to neurokinin b | |
| EP1633316A4 (en) | Antibodies that immunospecifically bind to trail receptors | |
| AU2002368062A1 (en) | Bispecific antibodies that bind to vegf receptors | |
| AU2003259835A1 (en) | Antibodies that immunospecifically bind to trail receptors | |
| AU2002352676A1 (en) | Antibodies that immunospecifically bind to trail receptors | |
| AU2003275834A1 (en) | ANTIBODIES THAT BIND alphaE INTEGRIN | |
| AU2001297702A1 (en) | Antibodies that immunospecifically bind to trail receptors | |
| AU2003228483A1 (en) | Antibodies that specifically bind to tr2 | |
| AU2002345927A1 (en) | Bispecific antibodies that bind to vegf receptors | |
| HK1094335A (en) | Monoclonal antibodies to gastrin hormone | |
| HK1066017A (en) | Antibodies that immunospecifically bind to trail receptors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |